Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy
Xiurong Cai, Zhan‐Hong Chen, Mengmeng Liu, Jin-Xiang Lin, Xiaoping Zhang, Jie Chen, Qu Lin, Xiaokun Ma, Jing‐Yun Wen, Sidong Xie, Xiangyuan Wu, Min Dong · Journal of Cancer · 2018
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2018
Abstract
Background: The Cancer of the Liver Italian Program (CLIP) score is commonly used for prognosis prediction of hepatocellular carcinoma (HCC).The CLIP includes the Child-Pugh grade, which is relatively subjective, for hepatic encephalopathy assessment.A newly developed scoring system called albumin-bilirubin grade (ALBI grade), consists of albumin and bilirubin to assess liver function reserve objectively.Here, we substituted the ALBI grade for the Child-Pugh grade to establish the ALBI-CLIP scoring system and validated its prognostic value in hepatitis B virus (HBV)-related HCC patients treated with trans-catheter arterial chemoembolization (TACE) therapy.
Methods:We retrospectively analyzed HBV-related HCC patients who received TACE therapy.Baseline characteristics were collected and evaluated to classify patients according to ALBI-CLIP, CLIP and TNM systems.Univariate analyses using the Kaplan-Meier method and the log-rank test, as well as multivariate analysis using the Cox proportional hazards regression model, were conducted to detect independent prognostic factors for overall survival.Receiver operating characteristic (ROC) curves and a likelihood ratio test (LRT) were both utilized to compare the values of ALBI-CLIP, CLIP and TNM staging systems in predicting survival.Results: With a total of 389 patients included in the current study, 301 (77.4%) and 88 (22.6%) were classified as Child-Pugh grade A and B, respectively.However, 152 (39.1%), 227 (58.4%) and 10 (2.5%) patients were correspondingly classified into ALBI grade 1, 2 and 3.The areas under the curves of ALBI-CLIP, CLIP and TNM systems were 0.804, 0.778 and 0.734, respectively, for predicting 3-month survival; 0.796, 0.778 and 0.733, respectively, for 6-month survival; 0.697, 0.687 and 0.644, respectively, for 1-year survival; and 0.618, 0.612 and 0.569, respectively, for 2-year survival.The LRT indicated that the ALBI-CLIP and the CLIP had similar values of χ 2 and Akaike information criterion (AIC) while the TNM system had the smallest χ 2 value (χ 2 = 12.1, 11.9, 10.5; AIC = 2620.2,2620.5, 2621.1 for ALBI-CLIP, CLIP and TNM, respectively).
Conclusions:In conclusion, our present study suggested that the ALBI-CLIP scoring system retained the prognostic value of the CLIP in HBV-related HCC treated with TACE therapy.
Open the resolved locator · 10.7150/jca.22925
Metadata licence: OpenAlex metadata (CC0)